VIB developed VHH technology for oral delivery

  • Therapeutic antibodies for oral ingestion to reach gastrointestinal targets 
  • Set up of a scalable, cost-effective microbial production process
     

POC in piglets, protected against ETEC infection

  • Together with Eric Cox (UGent Faculty of Veterinary Medicine)
  • Reduces need for antibiotics
     
VIB-UGent labs of Nico Callewaert & Ann Depicker, VIB-VUB lab of Henri De Greve

New spin-off Animab (°2020)

  • To bring product to the market
  • Seed round of 3.4 M€ led by Seventure Partners & PMV
  • with participations of Agri Investment Fund, V-Bio Ventures & VIB